|
NDC80 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.299800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.718420E-01 |
| Normal-vs-Stage2 |
7.386200E-01 |
| Normal-vs-Stage3 |
3.184600E-01 |
| Normal-vs-Stage4 |
7.137600E-02 |
| Stage1-vs-Stage2 |
7.378300E-03 |
| Stage1-vs-Stage3 |
5.323400E-01 |
| Stage1-vs-Stage4 |
2.766000E-01 |
| Stage2-vs-Stage3 |
3.244400E-02 |
| Stage2-vs-Stage4 |
2.484100E-03 |
| Stage3-vs-Stage4 |
1.854430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.508410E-01 |
| Normal-vs-AfricanAmerican |
8.270000E-01 |
| Normal-vs-Asian |
1.361180E-01 |
| Caucasian-vs-AfricanAmerican |
2.064000E-01 |
| Caucasian-vs-Asian |
6.711400E-01 |
| AfricanAmerican-vs-Asian |
1.789610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.916200E-02 |
| Normal-vs-Female |
3.231400E-01 |
| Male-vs-Female |
1.085800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.920200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.447200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.239600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.833600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.623700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.109800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.128200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.795440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.209390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.624100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.465600E-01 |
| Classical-VS-Follicular |
1.302740E-03 |
| Classical-VS-Other |
4.705400E-01 |
| Classical-VS-Normal |
1.250970E-01 |
| Tall-VS-Follicular |
1.363810E-02 |
| Tall-VS-Other |
3.685800E-01 |
| Tall-VS-Normal |
1.245450E-01 |
| Follicular-VS-Other |
7.084400E-01 |
| Follicular-VS-Normal |
9.348000E-01 |
| Other-VS-Normal |
7.716600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.883600E-01 |
| Normal-vs-N1 |
1.381580E-01 |
| N0-vs-N1 |
2.625600E-01 |
|
|
